Medicines Co. (MDCO) Posts Narrower-than-Expected Q3 Loss

October 26, 2016 7:02 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($0.64), $0.66 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $37.6 million versus the consensus estimate of $37.26 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment